UTIpure Effervescent Granules

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

Citric acid anhydrous; Sodium Bicarbonate; Sodium Citrate Anhydrous; Tartaric Acid

Boleh didapati daripada:

Live-Well Nutraceuticals Sdn. Bhd.

INN (Nama Antarabangsa):

Citric acid anhydrous; Sodium Bicarbonate; Sodium Citrate Anhydrous; Tartaric Acid

Unit dalam pakej:

12sachet Sachets; 28sachet Sachets; 1sachet Sachets; 2sachet Sachets; 3sachet Sachets; 4sachet Sachets; 5sachet Sachets; 6sachet Sachets; 7sachet Sachets; 8sachet Sachets; 9sachet Sachets; 10sachet Sachets; 14sachet Sachets; 15sachet Sachets; 16sachet Sachets; 18sachet Sachets; 20sachet Sachets; 24sachet Sachets; 28sachet Sachets; 60sachet Sachets; 80sachet Sachets; 100sachet Sachets; 120sachet Sachets; 144sachet Sachets

Dikeluarkan oleh:

Noripharma Sdn. Bhd.

Ciri produk

COMPOSITION:
EACH 4G SACHET CONTAINS:
Sodium bicarbonate
1,760 mg
Sodium citrate anhydrous
630 mg
Citric acid anhydrous
720 mg
Tartaric acid
890 mg
Also contains lime flavor.
DESCRIPTION:
Appearance of powder: White to off-white granular powder with odour of
lime flavour
Appearance of solution: Clear to slight haze solution with odour of
lime flavour
PHARMACOLOGY:
Sodium bicarbonate acts as urinary alkalinizer by increasing the
excretion of free bicarbonate ions in the
urine, thus effectively raising the urinary pH. By maintaining
alkaline urine, the actual dissolution of uric acid
stones may be accomplished.
Sodium Citrate and Citric Acid:
A rise in urinary pH increases the solubility of cysteine in the urine
and the ionization of uric acids to more
soluble urate ion. By maintaining alkaline urine, the actual
dissolution of uric acid stones may be
accomplished.
Tartaric acid in combination with bicarbonates acts as the acid
component of effervescent granules.
PHARMACOKINETIC:
Sodium citrate is metabolized to bicarbonates, which increases urinary
pH by increasing the excretion of free
bicarbonate ions, without producing systemic alkalosis when
administered in recommended doses. Sodium
bicarbonate is excreted through renal and also via lung by forming CO
2
. Sodium citrate, citric acid and
absorbed tartaric acid are excreted through urine.
INDICATIONS:
•
For relieving discomfort in mild urinary tract infections (UTI).
•
For symptomatic relief of dysuria (painful or difficult urination).
•
To enhance the action of certain antibiotics, especially
sulphonamides.
•
For prevention of urates crystallization in gout therapy.
DOSAGE AND ADMINISTRATION:
4g to 8g (1 to 2 sachets) dissolved in cold water four times daily for
5 days or as directed by the physician.
CONTRAINDICATIONS:
•
Renal failure or hypernatremia.
•
Concurrent hexamine mandelate or hexamine hippurate therapy.
•
Caution is advised in overt and occult cardiac failure.
•
Concomitant use of urinary alkalinizers and quinolone antibiotics
shoul